Pharmaceutical Policy Reforms to Regulate Drug Prices in Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea

Value in Health Regional Issues - United States
doi 10.1016/j.vhri.2018.08.007